Loading…
Zhongchao Inc. is projected to decline to $1.35 by 2027, a -13% move from its current price of $1.55. ZCMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.48 | $1.55 | $1.62 | -0.09% |
| May 30 | $1.45 | $1.55 | $1.65 | -0.19% |
| May 31 | $1.43 | $1.55 | $1.67 | -0.28% |
| Jun 1 | $1.41 | $1.54 | $1.69 | -0.38% |
| Jun 2 | $1.39 | $1.54 | $1.71 | -0.47% |
| Jun 3 | $1.38 | $1.54 | $1.73 | -0.57% |
| Jun 4 | $1.36 | $1.54 | $1.74 | -0.66% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.36 | $1.54 | $1.74 | -0.66% |
| Week 2 | $1.29 | $1.53 | $1.82 | -1.32% |
| Week 3 | $1.23 | $1.52 | $1.88 | -1.97% |
| Week 4 | $1.18 | $1.51 | $1.93 | -2.62% |
| Week 5 | $1.14 | $1.50 | $1.97 | -3.26% |
| Week 6 | $1.10 | $1.49 | $2.01 | -3.90% |
| Week 7 | $1.07 | $1.48 | $2.04 | -4.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs.
The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program.
It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Zhongchao Inc. (ZCMD) operates in the Healthcare sector with a current price of $1.55 and a market capitalization of $5.97M. It is ranked 5226 by market size, categorizing it as a relatively small-cap player in the market.
The price outlook derived from the provided forecast shows a mixed path, with the average price expected to move from $1.55 in 2026 toward higher levels by the late decade and beyond, including a long-term bullish trajectory to $1.88 in 2030 (ROI 21.3%), $2.09 in 2040 (ROI 34.9%), and $4.87 in 2050 (ROI 214.2%). In the near term, the forecast also foresees softer years, such as 2027 and 2028, before a longer-term uptrend. The small-cap status implies higher volatility and sensitivity to market dynamics while offering potential upside as the forecast extends into the 2030s and 2040s.
A major floor 39.1% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
The nearest ceiling, 43.2% above — a clean break opens room to run.
A major ceiling 157.0% above — clearing it would confirm fresh momentum.
Key ZCMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZCMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.50 | Buy | $1.51 | Buy |
| MA 10 | $1.51 | Buy | $1.55 | Sell |
| MA 20 | $1.74 | Sell | $1.67 | Sell |
| MA 50 | $1.84 | Sell | $1.90 | Sell |
| MA 100 | $2.29 | Sell | $2.57 | Sell |
| MA 200 | $4.41 | Sell | $4.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.45 | Neutral |
| Stoch RSI (14) | 48.77 | Neutral |
| CCI (20) | -42.34 | Neutral |
| Williams %R (14) | -82.86 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -1.90 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 17.14 | Buy |
| TRIX (15) | -0.87 | Sell |
| Awesome (5,34) | -0.37 | Sell |
| Ultimate (7,14,28) | 45.89 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 1.46 | Buy |
| ADX (14) | 27.37 | Sell |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is bearish in sentiment, with RSI14 at 40. The stock trades below the SMA50 of $1.84 and well below the SMA200 of $4.41, suggesting near-term weakness. Support is identified at $1.43 and resistance at $2.22, highlighting a defined but narrowing trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.43 | $1.55 | $1.96 | 0% | Neutral | |
| $1.00 | $1.35 | $1.97 | -13% | Neutral | |
| $0.7798 | $1.11 | $1.70 | -29% | Bearish | |
| $1.07 | $1.58 | $2.54 | +2% | Neutral | |
| $1.22 | $1.88 | $3.13 | +21% | Bullish | |
| $1.07 | $1.71 | $2.94 | +10% | Neutral | |
| $1.10 | $1.81 | $3.19 | +17% | Neutral | |
| $0.9463 | $1.61 | $2.92 | +4% | Neutral | |
| $0.8831 | $1.55 | $2.87 | 0% | Neutral | |
| $1.05 | $1.89 | $3.58 | +22% | Bullish | |
| $0.9976 | $2.09 | $4.30 | +35% | Bullish | |
| $2.19 | $4.87 | $11.20 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.43 | $1.55 | $1.84 | +0.00% |
| June 2026 | $1.26 | $1.50 | $1.85 | -3.01% |
| July 2026 | $1.18 | $1.42 | $1.79 | -5.43% |
| August 2026 | $1.19 | $1.46 | $1.87 | +2.78% |
| September 2026 | $1.22 | $1.50 | $1.95 | +2.93% |
| October 2026 | $1.16 | $1.44 | $1.89 | -4.23% |
| November 2026 | $1.12 | $1.41 | $1.87 | -2.02% |
| December 2026 | $1.15 | $1.46 | $1.96 | +3.35% |
Click any year to see its month-by-month ZCMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ZCMD price prediction for 2026 points to an average of $1.55 (low $1.43, high $1.96) — a potential gain of 0% on today's $1.55. A consolidation phase looks the most probable path here.
In 2027, ZCMD is projected to trade between $1.00 and $1.97, averaging $1.35 — a potential decline of -13% from today's $1.55. That is -13% versus the projected 2026 average. Price action looks broadly range-bound.
Zhongchao Inc.'s 2028 outlook centres on $1.11, within a $0.7798 to $1.70 range. That is -18% versus the projected 2027 average. That marks a -29% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2029, ZCMD could reach as high as $2.54, with a base case around $1.58 and support toward $1.07 — roughly +2% from $1.55. Price action looks broadly range-bound.
Expect ZCMD to range from $1.22 to $3.13 through 2030. The $1.88 average target implies a +21% move from current prices. That is up +19% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ZCMD price prediction for 2031 points to an average of $1.71 (low $1.07, high $2.94) — a potential gain of +10% on today's $1.55. Price action looks broadly range-bound.
In 2032, ZCMD is projected to trade between $1.10 and $3.19, averaging $1.81 — a potential gain of +17% from today's $1.55. That is up +6% on the projected 2031 average. A consolidation phase looks the most probable path here.
Zhongchao Inc.'s 2033 outlook centres on $1.61, within a $0.9463 to $2.92 range. That is -11% versus the projected 2032 average. That marks a +4% change versus current levels. Price action looks broadly range-bound.
By 2034, ZCMD could reach as high as $2.87, with a base case around $1.55 and support toward $0.8831 — roughly 0% from $1.55. A consolidation phase looks the most probable path here.
Expect ZCMD to range from $1.05 to $3.58 through 2035. The $1.89 average target implies a +22% move from current prices. That is up +22% on the projected 2034 average. Momentum favours further upside here.
The ZCMD price prediction for 2040 points to an average of $2.09 (low $0.9976, high $4.30) — a potential gain of +35% on today's $1.55. Buyers look set to stay in control over this stretch.
In 2050, ZCMD is projected to trade between $2.19 and $11.20, averaging $4.87 — a potential gain of +214% from today's $1.55. That is up +133% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ZCMD today (≈ 645.16129 ZCMD) could be worth
$3,141.78
+$2,141.78 (+214%) by 2050 · US Dollar
Based on the average projected ZCMD price of $4.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZCMDwould be worth at today's price.
$1,000 invested in ZCMD on May 27, 2025 (≈ 108.695654 ZCMD) would be worth
$168.48
-$831.52 (-83.2%) today · 0.17× · US Dollar
Based on a ZCMD entry price of $9.2 vs. today's $1.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.58 | $981.01 | -1.9% |
| 1 month ago | $2.09 | $741.63 | -25.8% |
| 3 months ago | $1.71 | $905.37 | -9.5% |
| 6 months ago | $5.33 | $290.92 | -70.9% |
| 1 year ago | $9.2 | $168.48 | -83.2% |
| All time (5.0y) ago | $141.6 | $10.95 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZCMD forecast.
Our base-case forecast reaches $3.10 around 2050.
Implied market cap at $3.10: $10.01M
Over the multi-year horizon, the forecast points to a bullish path from 2030 onward, with 2030 Avg $1.88 and ROI 21.3%, 2040 Avg $2.09 and ROI 34.9%, and 2050 Avg $4.87 and ROI 214.2%. The earlier years show more modest or negative moves, with 2027 Avg $1.35 (ROI -12.6%) and 2028 Avg $1.11 (ROI -28.6%). The long-term upside is substantial if the forecast plays out, but there is notable risk and volatility in the near term, including potential declines through 2028 before a sustained uptrend develops into the 2030s and 2040s.
Tap a question to reveal the answer.
The forecast shows an Avg price of $1.88 with ROI 21.3% and sentiment Bullish in 2030.
Forecasts indicate neutral to bearish conditions in 2026–2028, followed by bullish potential in 2030, 2040, and 2050 with ROI of 21.3%, 34.9%, and 214.2% respectively, but these are estimates and not guarantees.
The max forecast for 2030 is $3.13, offering a potential upside relative to the current price, but it is not guaranteed.
Current price is $1.55 and market cap is $5.97M.
The 30-day range is between $1.14 and $2.10.
Zhongchao Inc. Community Discussion
0Share your Zhongchao Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.